Unusual hepatorenal symptoms in amyloidosis;Ungewohnliche ursache einer hepatorenalen symptomatik

Medizinische Klinik

Volumn 94, Issue 5, 1999, Pages 274-278

  Frank, Helga ^a   Krammer, Manfred ^a   Fierlbeck, Wolfgang ^b   Rieß, Regine ^c   Geiger, Helmut ^b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b GOETHE UNIVERSITY   (Germany)

^c KLINIKUM NÜRNBERG   (Germany)

Author keywords

Amyloidosis; Hepatorenal symptoms; Low grade non Hodgkin's lymphoma

Indexed keywords

ALKALINE PHOSPHATASE; AMYLOID; BILIRUBIN; CREATININE; GAMMA GLUTAMYLTRANSFERASE; IMMUNOGLOBULIN LIGHT CHAIN;

AGED; ARTICLE; CASE REPORT; CHOLESTASIS; CREATININE BLOOD LEVEL; DIFFERENTIAL DIAGNOSIS; HEPATORENAL SYNDROME; HUMAN; HUMAN TISSUE; KIDNEY AMYLOIDOSIS; KIDNEY BIOPSY; NONHODGKIN LYMPHOMA; PROTEINURIA; VIRUS HEPATITIS; AMYLOIDOSIS; B CELL LYMPHOMA; BIOPSY; BONE MARROW; KIDNEY; KIDNEY DISEASE; LIVER; LIVER DISEASE; MALE; PATHOLOGY;

AGED; AMYLOIDOSIS; BIOPSY; BONE MARROW; DIAGNOSIS, DIFFERENTIAL; HEPATORENAL SYNDROME; HUMANS; KIDNEY; KIDNEY DISEASES; LIVER; LIVER DISEASES; LYMPHOMA, B-CELL; LYMPHOMA, LOW-GRADE; MALE;

EID: 0033561891     PISSN: 07235003     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03045051     Document Type: Article

References (14)

1. Baretton G, Linke RP, Löhrs U. Systemische Amyloidosen: Immunhistochemische Typisierung an Autopsien mit Hilfe zahlreicher spezifischer Antikörper. Pathologe 1990;11:71-9.
2. Cohen AS, Rubinow JJ, Skinner M, Mason JH, Libbey C, Kayne F. Survival of patients with primary (AL) amyloidosis: cases treated with colchicine from 1976-1983 compared with cases seen in previous years 1961-1973. Am J Med 1987;82:1182-90.
3. Fischer JL, Cyran J, Linke RP. Neue Aspekte der Klassifikation. Diagnostik und Therapie der Amyloidosen. Internist 1986;27:109.
4. Glenner GG. Amyloid deposits and amyloidosis: the beta fibrilloses. N Engl J Med 1980;302:1283-92:1333-43.
5. Hemmington L, Eriksson P. Cardiac amyloidosis mimicking hypertrophic cardiomyopathy. Acta Med Scand 1986;219:421.
6. Hetzel GR, Grabensee B. Systemische Amyloidosen, Dtsch. Med. Wochenschr 1995;120:1479-85.
7. Hubsy G, Sletten K. Chemical and clinical classification of amyloidosis. Scand J Immunol 1986;23:253.
8. Klein HH. Bedeutung von Elektro-und Echokardiogramm in der Diagnostik der kardialen Amyloidose. Dtsch Med Wochenschr 1991;116:13.
9. Kyle RA, Gertz AG, Greipp PR, Witzig TE, Lust JA, Lacy MQ, Therneau TM. A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone and colchicine. N Engl J Med 1997;336:1202-7.
10. Kyle RA, Greipp PR. Amyloidosis (AL): clinical and laboratory features in 229 cases. Mayo Clin Proc 1983; 58:665.
11. Kyle RA, Greipp PR, Gorton JP, Gertz MA. Primary systemic amyloidosis. Comparison of melphalan/prednisone versus colchicine. Am J Med 1985;79:708.
12. Scott PP, Scott WW, Siegelmann SS. Amyloidosis: an overview. Sem Roentgenol 1986;21:103.
13. Voigt C, Saeger W, Linke RP, Missmahl HP. Immunhistochemische Differenzierung von generalisierten Amyloidosen. Pathologe 1989;10:103.
14. Watanabe S, Jaffe E, Pollock S, Sipe J, Glenner G. Amyloid AA proteins. Cellular distribution and appearance. Am J Clin Pathol 1977;67:540-4.